Search
for

    Sort by

    Research 571–600 of 1000+

    1. Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis Dermatology Reports · 2026 · 1 citations
    2. Menopause and Common Dermatoses: A Systematic Review American Journal of Clinical Dermatology · 2025 · 1 citations
    3. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    4. Mechanism of PPARα agonist in alopecia areata American Journal of Translational Research · 2025 · 1 citations
    5. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion IP Indian Journal of Clinical and Experimental Dermatology · 2024 · 1 citations
    6. Efficacy of therapy with 311nm narrow-band UVB 311nm in the treatment of patients with alopecia areata associated with atopic dermatitis Meditsinskiy sovet = Medical Council · 2023 · 1 citations
    7. Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles Clinical, cosmetic and investigational dermatology · 2023 · 1 citations
    8. Janus Kinase inhibitors in dermatology: a review Portuguese Journal of Dermatology and Venereology · 2023 · 1 citations
    9. New therapies for alopecia areata Bőrgyógyászati és Venerológiai Szemle · 2021 · 1 citations
    10. Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl International Journal of Dermatology · 2019 · 1 citations
    11. Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment 2018 · 1 citations
    12. 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata Journal of Investigative Dermatology · 2018 · 1 citations
    13. Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2018 · 1 citations
    14. Current systemic treatment strategies for hidradenitis suppurativa Expert opinion on orphan drugs · 2017 · 1 citations
    15. Biomaterials for dermal substitutes Elsevier eBooks · 2016 · 1 citations
    16. Transplantation of melanocyte stem cells in vitiliginous skin Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · 2015 · 1 citations
    17. Melanocytes and Vitiligo (and Hair Graying) Elsevier eBooks · 2014 · 1 citations
    18. Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases 2026
    19. DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT International Journal of Applied Pharmaceutics · 2026
    20. Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy Frontiers in Immunology · 2026
    21. Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    22. Follicular Atopic Dermatitis in Dark Skin Cureus · 2026
    23. Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications Journal of Skin and Sexually Transmitted Diseases · 2026
    24. Skin aging: mechanisms, evaluation, and rejuvenation The EMBO Journal · 2026
    25. A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata Jurnal Sehat Indonesia (JUSINDO) · 2026
    26. Skin manifestations of hyperandrogenism: an update HORMONES · 2026
    27. Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia International Journal of Homoeopathic Sciences · 2026
    28. Potential therapeutic applications of mesenchymal stem cell-derived extracellular vesicles DiRROS repository (University of Maribor) · 2026
    29. Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review Dermatology and Therapy · 2026
    30. Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system Frontiers in Medicine · 2026